Cite
Guerini-Rocco E, Gray KP, Fumagalli C, et al. Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clin Cancer Res. 2020;27(2):504-512doi: 10.1158/1078-0432.CCR-20-0126.
Guerini-Rocco, E., Gray, K. P., Fumagalli, C., Reforgiato, M. R., Leone, I., Rafaniello Raviele, P., Munzone, E., Kammler, R., Neven, P., Hitre, E., Jerusalem, G., Simoncini, E., Gombos, A., Deleu, I., Karlsson, P., Aebi, S., Chirgwin, J., Di Lauro, V., Thompson, A., Graas, M. P., Barber, M., Fontaine, C., Loibl, S., Gavilá, J., Kuroi, K., Müller, B., O'Reilly, S., Di Leo, A., Goldhirsch, A., Viale, G., Barberis, M., Regan, M. M., & Colleoni, M. (2021). Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(2), 504-512. https://doi.org/10.1158/1078-0432.CCR-20-0126
Guerini-Rocco, Elena, et al. "Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,2 (2021): 504-512. doi: https://doi.org/10.1158/1078-0432.CCR-20-0126
Guerini-Rocco E, Gray KP, Fumagalli C, Reforgiato MR, Leone I, Rafaniello Raviele P, Munzone E, Kammler R, Neven P, Hitre E, Jerusalem G, Simoncini E, Gombos A, Deleu I, Karlsson P, Aebi S, Chirgwin J, Di Lauro V, Thompson A, Graas MP, Barber M, Fontaine C, Loibl S, Gavilá J, Kuroi K, Müller B, O'Reilly S, Di Leo A, Goldhirsch A, Viale G, Barberis M, Regan MM, Colleoni M. Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clin Cancer Res. 2021 Jan 15;27(2):504-512. doi: 10.1158/1078-0432.CCR-20-0126. Epub 2020 Oct 20. PMID: 33082214.
Copy
Download .nbib